VolitionRx Ltd (VNRX) - Operating Profitability

VolitionRx Limited (VNRX) - corporate logo

VolitionRx Limited (VNRX) is implementing automated AI systems for epigenetic blood scanning. The company's revenues are based on the commercialization of Nu.Q for human and animal oncology diagnostics. The operating margin demonstrates business resilience, with -512.60 serving as the current value of this metric. Process efficiency is further enhanced by the express delivery of reagents, ensuring uninterrupted laboratory operations and high analysis speeds.

VolitionRx Ltd. (VNRX): Operating Profitability from 07/04/2022 to 11/19/2026

Financial and market metric breakdowns for VolitionRx Ltd. (VNRX)

- market capitalization indicators:
Initial company analysis:VNRX, VolitionRx Limited
Brand item of VolitionRx

Operating margin is calculated as the ratio of operating income to revenue, reflecting the efficiency of the core business before accounting for debt load and taxes. This metric allows for an assessment of a company's ability to generate cash flow, while the operating margin of VolitionRx Limited (VNRX) is currently limited by expansion costs for Nu.Q platforms within the conservative laboratory network segment.